reports
- Anthony Dick
- Marc Lavaud
- Michael Foundoukidis
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
RNO RENAULT SA
APAML APERAM SA
VOLV B VOLVO AB CLASS B
OUT1V OUTOKUMPU OYJ
EO FAURECIA SA
RI PERNOD RICARD SA
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
POM PLASTIC OMNIUM SE
SZG SALZGITTER AG
TYRES NOKIAN RENKAAT OYJ
KCO KLOECKNER & CO SE
COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
JCQ JACQUET METALS SA
VOE VOESTALPINE AG
ACX ACERINOX SA
FR VALEO SE
VOW3 VOLKSWAGEN AG PREF
EZJ EASYJET PLC
CIE CIE AUTOMOTIVE S.A.
RACE FERRARI NV
PIRC PIRELLI & C. S.P.A.
STM STMICROELECTRONICS NV
GEST GESTAMP AUTOMOCION S.A.
8TRA TRATON SE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
DTG DAIMLER TRUCK
IVG IVECO GROUP
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
- Anthony Dick
- Marc Lavaud
- Michael Foundoukidis
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
RNO RENAULT SA
APAML APERAM SA
VOLV B VOLVO AB CLASS B
OUT1V OUTOKUMPU OYJ
EO FAURECIA SA
RI PERNOD RICARD SA
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
POM PLASTIC OMNIUM SE
SZG SALZGITTER AG
TYRES NOKIAN RENKAAT OYJ
KCO KLOECKNER & CO SE
COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
JCQ JACQUET METALS SA
VOE VOESTALPINE AG
ACX ACERINOX SA
FR VALEO SE
VOW3 VOLKSWAGEN AG PREF
EZJ EASYJET PLC
CIE CIE AUTOMOTIVE S.A.
RACE FERRARI NV
PIRC PIRELLI & C. S.P.A.
STM STMICROELECTRONICS NV
GEST GESTAMP AUTOMOCION S.A.
8TRA TRATON SE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
DTG DAIMLER TRUCK
IVG IVECO GROUP
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
- Geoffroy Michalet
- Geoffroy Michalet
Koninklijke Ahold Delhaize N.V.: 1 director
A director at Koninklijke Ahold Delhaize N.V. sold 58,000 shares at 34.380EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
BUREAU VERITAS: Number of shares and voting rights as of November 30, ...
BUREAU VERITAS: Number of shares and voting rights as of November 30, 2025 REGULATED INFORMATION Courbevoie, France – December 15, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights30/11/2025453,916,256 Theoretical number of voting rights: 560,890,697 Number of exercisable voting rights: 550,627,131 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since Ja...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre ...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre 2025 INFORMATION RÈGLEMENTÉE Courbevoie, France – 15 décembre 2025 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêté Nombre d’actions en circulation (1) Nombre total de droits de vote 30/11/2025 453 916 256 Nombre de droits de vote théoriques : 560 890 697 Nombre de droits de vote exerçables : 550 627 131 (1) y compris les ac...
Bureau Veritas - New appointments to the Board of Directors
Bureau Veritas - New appointments to the Board of Directors PRESS RELEASE Courbevoie – December 15th, 2025 New appointments to Bureau Veritas’ Board of Directors , a global leader in Testing, Inspection and Certification (TIC), announces that the Board of Directors, under the chairmanship of Mr. Laurent Mignon, has appointed Mr. Geoffroy Roux de Bézieux as Lead Independent Director, Chairman of the Nomination & Compensation Committee, and Vice-Chairman of the Company’s Board of Directors, replacing Mr. Pascal Lebard who no longer qualifies as independent after twelve years of directorshi...
Bureau Veritas - Nouvelles nominations au sein du Conseil d’administra...
Bureau Veritas - Nouvelles nominations au sein du Conseil d’administration COMMUNIQUE DE PRESSE Courbevoie – 15 décembre 2025 Nouvelles nominations au sein du Conseil d’administration de Bureau Veritas , un leader mondial des essais, de l’inspection et de la certification, annonce que le Conseil d’administration, sous la présidence de Monsieur Laurent Mignon, a nommé Monsieur Geoffroy Roux de Bézieux en qualité d’Administrateur Référent indépendant, de Président du Comité des nominations et des rémunérations et de Vice-Président du Conseil d’administration de la Société, en rempl...
- Dominic Rose
- Naresh Chouhan
Thematic - 2026 Outlook - "5 More Years" (55pgs)
For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...
- Eya Drira
- Geoffroy Michalet
- Eya Drira
- Geoffroy Michalet
- Eya Drira
- Geoffroy Michalet
BUREAU VERITAS: Number of shares and voting rights as of November 30, ...
BUREAU VERITAS: Number of shares and voting rights as of November 30, 2025 REGULATED INFORMATION Courbevoie, France – December 8, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights30/11/2025453,916,256Theoretical number of voting rights: 560,890,697 Number of exercisable voting rights: 550,627,131 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since Janua...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre ...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre 2025 INFORMATION RÈGLEMENTÉE Courbevoie, France – 8 décembre 2025 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêté Nombre d’actions en circulation (1) Nombre total de droits de vote 30/11/2025 453 916 256 Nombre de droits de vote théoriques : 560 890 697 Nombre de droits de vote exerçables : 550 627 131 (1) y compris les...
- Hilde Van Boxstael
- Mathijs Geerts Danau
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Mathijs Geerts Danau
UCB Detailed results from Fintepla in CDD strengthen epilepsy franchis...
UCB presented detailed results of the positive phase 3 GEMZ study with Fintepla in CDKL5 deficiency disorder (CDD). The drug showed an estimated 52.7% median reduction in countable motor seizure frequency (CMSF) compared with placebo during a 14 week titration and maintenance period and a favourable safety profile. We view this as highly encouraging in this refractory epilepsy population. Given the infantile onset of CDD, we will be curious to see as of which age, patients could be included in t...
- Ahmed Ben Salem
- Baptiste Salaville
- Oddo Sustainability Team
- Martial Descoutures
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.